Skip to main content

Manulife Fin(MFC-T)

Today's Change
Real-Time Last Update

Closing Bell: Manulife Fin down on Wednesday (MFC)

Automated Summaries - The Globe and Mail - Wed Apr 24, 4:01PM CDT

In today's trading, Manulife Fin shares opened at $32.15 and closed at $32.15. It traded at a low of $32.04 to a high of $32.41.

The price eased -0.19 percent from the previous day's close of $32.21.

During the day across North America, the TSX Composite closed -0.63% at 21873.72, the S&P 500 closed 1.20% at 5070.55, the Dow Jones Industrial Average closed 0.69% at 38503.69 and the Nasdaq Composite closed 1.59% at 15696.64.

Manulife Fin has listed on the Toronto Stock Exchange (TSX) under the ticker MFC.

Trading volume was 3,755,257 on 7,766 total trades. On average, Manulife Fin has traded 4,569,250 shares over 5 days and 6,059,923 year-to-date.

The TSX overall saw 2,208 price advancers against 2,970 declines and 124 unchanged.

During the prior 52 weeks, MFC.TO has traded as high as $34.05 (March 28,2024) and low as $23.69 (October 27,2023). Moreover, in the last 12 months, Manulife Fin's shares have advanced 22.48 percent, while they have advanced 9.80% this year.

It announced a 0.40 dividend on February 14/24, with an February 27/24 ex-date and March 19/24 pay day.

Following today's trading, Manulife Fin has a market capitalization of $58.16 billion on a float of 1,806,118 shares outstanding. Its annual EPS is $2.61.

Manulife Fin is a TSX Insurance company headquartered in Toronto, CAN.

Manulife Fin's average recommendation is "Moderate Buy" based on 12.00 analysts according to Zacks. Currently, there are 8 buy ratings and 4 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe

inside the market
Short sales on the TSX: What bearish investors are betting against
Larry MacDonald